Celldex Therapeutics (CLDX) FCF Margin Growth (3y) (2013 - 2026)
Celldex Therapeutics (CLDX) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Celldex Therapeutics |
2.16 Bn |
2.16 Bn |
-1.44 Mn |
-44.52 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-44.52 Mn |
| Dec 31, 2025 |
-5.25 Mn |
| Jun 30, 2025 |
792,855.00 |
| Mar 31, 2025 |
656,902.00 |
| Dec 31, 2024 |
162,594.00 |
| Sep 30, 2024 |
907,033.00 |
| Jun 30, 2024 |
-83,806.00 |
| Mar 31, 2024 |
-2.35 Mn |
| Dec 31, 2023 |
-65,949.00 |
| Sep 30, 2023 |
53,719.00 |
| Jun 30, 2023 |
-516,007.00 |
| Mar 31, 2023 |
-232,906.00 |
| Dec 31, 2022 |
-11,176.00 |
| Sep 30, 2022 |
-666,515.00 |
| Jun 30, 2022 |
-1.25 Mn |
| Mar 31, 2022 |
-1.35 Mn |
| Dec 31, 2021 |
-357,029.00 |
| Sep 30, 2021 |
-928,618.00 |
| Jun 30, 2021 |
29,466.00 |
| Mar 31, 2021 |
-202,757.00 |
